港股异动丨无惧关税威胁,港股药品股大涨,恒瑞医药涨超7%创新高

老虎资讯综合
09 Jul

周三,港股药品股集体拉升,其中,恒瑞医药涨7.5%创上市新高,德琪医药、绿叶制药涨近6%,中国生物制药、康哲药业、翰森制药、石药集团、开拓药业等跟涨。

消息上,美国总统特朗普周二在内阁会议期间表示,更多贸易协定即将出台,拟对进口铜加征50%关税,药品关税可能高达200%。有分析指出,药品是高度敏感的民生领域,大幅加征关税可能导致药价飙升,引发公众强烈反对。市场可能认为此类政策更可能是谈判筹码,实际执行概率低。

个股方面,恒瑞医药公布,子公司广东恒瑞医药收到国家药监局核准签发关于SHR-2173注射液的《药物临床试验批准通知书》,将于近期开展临床试验;基石药业-B与Istituto Gentili就舒格利单抗在西欧和英国达成独家战略合作;先声药业乐德奇拜单抗新药上市申请获国家药监局受理。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10